Heidelberg Pharma Ag Is A Biopharmaceutical Company Based In Ladenburggermanyspecializing In Oncology Therapeuticsfounded In 1997 And Rebranded In 2011The Company Focuses On Developing Antibody Drug Conjugatesadcsusing Proprietary Technologiesits Mission Is To Create Targeted Cancer Therapies That Enhance Treatment Efficacy And Tackle Drug Resistance The Company Utilizes Innovative Platforms Such As The Antibody Targeted Amanitin Conjugateatac Which Employs Amanitin To Specifically Target Cancer Cellsand Exatecan Based Adcs That Incorporate Topoisomerase I Inhibitorsheidelberg Pharma S Product Pipeline Includes Hdp 101A Clinical Candidate For Multiple Myelomaand Hdp 201Which Targets Undisclosed Antigensthe Company Also Engages In Partnerships To License Legacy Assets And Collaborate On Adc Technologiesenhancing Its Reach In The Oncology Market
